跳至主要内容
临床试验/NL-OMON30642
NL-OMON30642尚未招募2 期

The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. - DCSOCD

Meerkanten GGZ (Ermelo)0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with a primary DSM-IV diagnosis of OCD with an age of 18 years and older as established with the Structural Clinical Interview for axis I DSM-IV Disorders (SCID I)
  • - Obsessive-compulsive complaints has to be such that exposure in vivo is feasible at the outpatient department, in the clinic or the direct environment.
  • - Patients have to understand the rationale of exposure therapy and there has to be a readiness to participate in exposure sessions.
  • - If a patient uses medication, dosages have to be stable (no changes in the last 2 months and during the study period).
  • - Negative pregnancy test (β-HCG in urine).

排除标准

  • - Addiction to alcohol or drugs or abuse of these compounds
  • - A primary diagnosis of a personality disorder
  • - Psychotic disorder
  • - Relevant somatic disorders
  • - Suicidal intentions
  • - Pregnancy or breastfeeding
  • - Usage of medication possibly interfering with DCS (isoniazide, protonionamide)

研究者

发起方
Meerkanten GGZ (Ermelo)

相似试验

The effect of the addition of D-cycloserine to... | 临床试验